Dr. Malgorzata Szerszeniewska
President / Chief Executive Officer
Szerszeniewska is a co-founder of EastHORN. Previously, she was president of AbCRO, Inc., an American-owned CRO operating in Europe. Prior to that Dr. Szerszeniewska spent more than 10 years at Covance, where she held various positions including Regional Resource Manager, Project Manager, Director of Strategic Development and Clinical Operations in Europe, and was responsible for development of the company’s Clinical Development Services in the European region.
Before joining the CRO industry, she worked as an Anesthesiology and Intensive Care Specialist at Warsaw University Hospital. Dr. Szerszeniewska’s therapeutic experience includes oncology, neurology, cardiovascular, psychiatry and gastrointestinal medicine. Dr. Szerszeniewska received her Medical Diploma from the Warsaw Medical University.
Iain joined EastHORN in 2013 as Chief Business Officer to play a key role in the next stages of EastHORN’s ambitious plans for growth. He has been managing CRO business development in Europe and North America for more than 20 years. Since the first tentative steps into Poland and Hungary in the 90’s he has enjoyed and been a key part of the spectacular growth in clinical services in this region and beyond. Senior management roles as European Head and Global VP of Business Development have enabled Iain to be at the leading edge of business and corporate development within the global CRO industry.
Following the retirement of Dr Alan Wood from his position as Executive Chairman in 2021, Iain has succeeded Dr Wood and will ensure that the growth and development of the company under Alan’s and Dr Malgosia Szerszeniewska’s stewardship continues apace.
Iain is based in the UK and graduated in Cell Biology from the University of Glasgow.
Vice President Project Management
Ms Mohlberg joined EastHORN at the beginning of 2013 and established the office in Cologne, Germany to further enhance our services for Western European and German clients. She has worked in the clinical research field for over 16 years and is very aware of the important role of European countries in almost all clinical trials and the constant growth in the region
Having previously worked for both CROs and pharma companies, she is very familiar with the clinical research environment in Germany and internationally. With her understanding of the structure and needs, as well as challenges of the pharmaceutical industry, she ensures that the services delivered to our clients by our project teams are of the highest quality.
Ms Mohlberg graduated in biology from the University of Giessen, Germany
Dr. Tandy Amure
Chief Medical Officer
Dr Tandy Amure has over 27 years experience working as a Pharmaceutical Physician within the CRO industry. She started her career in 1994, as a Clinical Research Physician/Principal Investigator in Phase I Clinical Pharmacology Units in the UK.
Dr Amure joined a global CRO as Pharmaceutical Development Physician, where she held roles of increasing responsibilities during her 18 year tenure with the company. Dr Amure has extensive experience in medical monitoring, business development, process improvements, mentoring and client facing situations. She brings a wealth of experience in clinical development across multiple therapeutic areas and phases of clinical development.
Dr Amure is a Rheumatologist by training and obtained her medical degree from the University of Bristol, UK in 1988. She also has a BSc (Hons) in Physiology and a Masters degree in Pharmacology.
Dr Amure is based in the UK, and is GMC Registered.
Vice President, Global Business Development
Mark joined the EastHORN Business Development Team in 2015. In his role of Vice President of Global Business Development, Mark brings extensive experience to EastHORN from over 25 years in the CRO Industry.
Mark started his career in Clinical Operations in the 90s and has since lived and worked in both Europe and North America. Through close and careful collaboration with a wide range of Biotech and Pharma clients across a broad spectrum of Therapeutic Areas, Mark is fully aware of the pain points and challenges Clinical Trial Executives face when developing new therapies.
This understanding allows Mark to help our clients successfully execute and expedite their clinical trials goals.
Dr. Yvonne Tretter
Executive Director Clinical Operations
Dr Yvonne Tretter joined EastHORN Clinical Services in 2017 – she has more than 20 years of experienced working in the CRO industry – holding various positions including Director Project Management, Clinical Operations and Project Director.
She successfully managed many phase I, II & III, global and international trials for top pharmaceutical and biotech companies and ensured the highest level of the deliverables.
Yvonne gained her Dr. rer. Nat. in biology (neurobiology & biochemistry).
Vice President, Finance
Piotr joined the EastHORN Team in 2019. In his role of Vice President of Finance, Piotr brings extensive experience to EastHORN from over 20 years in FMCG, Chemical and Pharma Industry.
Piotr started his career in finance in the 90s and has held positions of progressive financial and business leadership at Henkel, Cognis and BASF, including in Poland, Germany, Norway and Russia.
Prior to joining EastHORN, Piotr held senior-level positions in both manufacturing and service companies including Qiagen, Frauenthal Automotive and Robinson Packaging.
Piotr holds a Master of Business Administration from the University of Gdańsk.